Cell line · CVCL_1650
Reh
Cancer cell line, Homo sapiens. Childhood B acute lymphoblastic leukemia. 73 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Reh. Cell lines, record CVCL_1650. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1650
On this page
Cell line
As Cellosaurus gives it.
- Name
- Reh
- Accession
- CVCL_1650
- RRID
- RRID:CVCL_1650
- Synonyms
- REH
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 15Y
- Category
- Cancer cell line
- Diseases
Childhood B acute lymphoblastic leukemia (NCIt C9140); B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1 (NCIt C80334); B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) (ORDO Orphanet_585929)
- Derived from
- Peripheral blood (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers73
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Development and validation of the IFN-γ FlowCytoScreen for cytokine-based potency assessment of advanced therapy medicinal products. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia. | Leukemia | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chemical Markers and Bioactivity of Algerian Royal Jelly: Influence of Bee Subspecies, Geography, and Lyophilization. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Interleukin-27 remodels the bone marrow niche to suppress B-cell development and leukaemia progression in mouse models. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Enhancing Anti-Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression. | Adv Sci (Weinh) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Highly specific Immunoproteasome inhibitor M3258 induces proteotoxic stress and apoptosis in KMT2A::AFF1 driven acute lymphoblastic leukemia. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile. | Mol Cancer Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway | Res Sq | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells. | Cancer Immunol Immunother | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 73
See all 73 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EU-1 | CVCL_8857 | Has a recorded problem | Cell lines |
| Derived from it | KM-3 | CVCL_0011 | Has a recorded problem | Cell lines |
| Derived from it | NOI-90 | CVCL_8462 | Has a recorded problem | Cell lines |
| Derived from it | Reh/EphA3 | CVCL_ZV66 | Cell lines | |
| Derived from it | WSU-CLL | CVCL_A049 | Has a recorded problem | Cell lines |
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-8286 | ATCC | |
| AddexBio | C0003031/4985 | Cellosaurus | |
| BCRJ | 0321 | BCRJ | |
| CLS | 300320 | CLS | |
| DSMZ | ACC-22 | DSMZ |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1650
GET https://conductscience.org/api/cell-lines/v1/CVCL_1650/papers?page=2